6-Chloro-2-methyl-2H-indazol-5-amine CAS 1893125-36-4 Pite > 98.0% (LCMS) Ensitrelvir (S-217622) Entèmedyè COVID-19

Deskripsyon kout:

Non: 6-Chloro-2-methyl-2H-indazol-5-amine

CAS: 1893125-36-4

Pite:> 98.0% (LCMS)

Aparans: Limyè mawon pou gri solid poud

Entèmedyè Ensitrelvir (S-217622), COVID-19

Segondè Kalite, Pwodiksyon Komèsyal

E-Mail: alvin@ruifuchem.com

Voye imèl ba nou

Pwodwi detay

Pwodwi ki gen rapò

Tags pwodwi

Deskripsyon:

Pwovizyon Komèsyal Ensitrelvir (S-217622) Entèmedyè:
S-Ethylisothiourea Hydrobromide CAS 1071-37-0
2,4,5-Trifluorobenzyl bromur CAS 157911-56-3
Trimethyloxonium Tetrafluoroborate CAS 420-37-1
6-Chloro-2-methyl-2H-indazol-5-amine CAS 1893125-36-4
3-(Chloromethyl)-1-methyl-1H-1,2,4-triazole hydrochloride CAS 135206-76-7
1,3,5-Triazine-2,4(1H,3H)-dyon, 3-(1,1-dimethylethyl)-6-(ethylthio)- CAS 1360105-53-8

Pwopriyete chimik:

Non Chimik	6-Chloro-2-methyl-2H-indazol-5-amine
Nimewo CAS	1893125-36-4
Nimewo CAT	RF-PI1506
Estati Stock	Nan stok
Fòmil molekilè	C8H8ClN3
Pwa molekilè	181.62
Mak	Ruifu Chimik

Espesifikasyon:

Atik	Espesifikasyon
Aparans	Limyè mawon pou gri solid poud
Pite / Metòd analiz	>98.0% (LCMS)
Spectre 1H RMN	Ki konsistan avèk estrikti
LCMS	Ki konsistan avèk estrikti
Pèt sou siye	≤1.00%
Enpurte total	<2.00%
Tès Creole	Enterprise Standard
Itilizasyon	Entèmedyè Ensitrelvir (S-217622), COVID-19

Pake & Depo:

Pake: Boutèy, 25kg/tanbou, oswa selon kondisyon kliyan an.

Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè ak imidite.

Avantaj:

FAQ:

Aplikasyon:

6-Chloro-2-methyl-2H-indazol-5-amine (CAS: 1893125-36-4) se yon entèmedyè nan Ensitrelvir (S-217622).Ensitrelvir pa Shionogi & Co. se yon dwòg antiviral trè efikas ki travay menm jan ak Paxlovid Pfizer a.Oral Xocova (Ensitrelvir), ki gen menm mekanis nan aksyon ak Paxlovid Pfizer a (Nirmatrelvir + Ritonavir), diferan nan ke li sèlman bezwen yo dwe pran yon fwa pa jou, pandan y ap efikasite nan terapetik nan ensitrelvir pa sanble yo dwe enferyè a Paxlovid.Kòm yon rapèl, Nirmatrelvir yo administre de fwa chak jou, ansanm ak rapèl ki reprezante pa Ritonavir.Ensitrelvir te vin premye grenn Japonè domestik ki te trete COVID-19, twazyèm ki te apwouve reglemante nan Japon;an fevriye 2022.